What did we learn from CTLA-4 insufficiency on the human immune system?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What did we learn from CTLA-4 insufficiency on the human immune system?

Published:2018-12-18 Issue:1 Volume:287 Page:33-49
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

Mitsuiki Noriko¹,Schwab Charlotte¹,Grimbacher Bodo¹

Affiliation:

1. Center for Chronic Immunodeficiency (CCI); Medical Center-University of Freiburg; Faculty of Medicine; University of Freiburg; Freiburg Germany

Funder

Bundesministerium für Bildung und Forschung

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imr.12721/fullpdf

Reference149 articles.

1. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses;Walker;Nat Rev Immunol,2011

2. A molecular perspective of CTLA-4 function;Teft;Annu Rev Immunol,2006

3. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4;Kuehn;Science,2014

4. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations;Schubert;Nat Med,2014

5. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects;Schwab;J Allergy Clin Immunol,2018

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular basis of proximal small intestine disorders;Nature Reviews Gastroenterology & Hepatology;2024-08-08

2. Elucidating CTLA-4’s role in tumor immunity: a comprehensive overview of targeted antibody therapies and clinical developments;Molecular Diversity;2024-07-10

3. Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy;Cell Communication and Signaling;2024-04-03

4. Assessment of CTLA-4 Gene Expression Levels on CD8+ T Cells in Renal Transplant Patients and Relation with Serum sCTLA-4 Levels;Biochemical Genetics;2024-03-11

5. Immune Checkpoint Inhibitor-Associated Systemic Sclerosis in the Treatment of a Small Cell Lung Cancer Patient with Durvalumab: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3